BridgeMD
New treatment option for Cerebral Palsy (CP)
Official title Spastic Myopathy in Adults With Cerebral Palsy
ClinicalTrials.gov ID: NCT07293988
What this study is testing
- What it's testing
- Cerebral palsy (CP) is indeed the result of a central neurological lesion, but it also involves a lesser-known muscular condition that we refer to as spastic myopathy. This condition is likely the consequence of relative immobilization and underuse of the muscles in the affected limbs and, through a vicious cycle, it in turn plays a major role in movement difficulties.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Hemiparesis or diparesis resulting from a cerebral lesion occurring during the perinatal period (cerebral palsy).
- Gastrocnemius extensibility XV1 \< 100° (XV1, Tardieu Scale).
- Maximum barefoot walking speed (AT10) between 0.3 and 1.2 m/s.
- Written informed consent to participate in the study.
You likely can't join if
- Botulinum toxin injections in the medial gastrocnemius within less than 3 months prior to study inclusion.
- Cognitive impairment preventing participation in the GSC program or in the study.
- Patients under legal guardianship or conservatorship.
- Known hemostasis disorders.
- Hypersensitivity to allergens.
- Presence of a metallic intraocular foreign body (accidental fragments or others), a pacemaker, a neurostimulator (pain treatment), a cochlear...
The study team makes the final eligibility decision.
Where it's taking place
- Créteil, Île-de-France Region, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Créteil, Île-de-France Region, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.